Literature DB >> 26209503

Transcriptional regulation of the VEGF gene in dependence of individual genomic variations.

Carmen S Metzger1, Dimitrios Koutsimpelas1, Juergen Brieger2.   

Abstract

Overexpression of the vascular endothelial growth factor (VEGF) gene has been associated with advanced stage and poor survival in several cancers. The majority of disease-associated VEGF-single nucleotide polymorphisms (SNPs) locate within regulatory regions. Therefore, an influence of SNPs located in the promoter/5'-untranslated region (5'UTR) on transcription factor binding (TFB) and gene expression seems feasible. We reviewed the literature investigating a potential connection of VEGF-SNPs and transcriptional regulation of the VEGF gene. In addition, we employed transcription factor databases to search for VEGF-SNPs which have already been associated with diseases. The objective of this review is to gain an overview about an association of VEGF-SNPs and the transcription factor dependent regulation of the VEGF gene. A decreasing binding specificity of the transcription factor MZF1 in presence of the VEGF-SNP +405 C-allele has been reported. TF databases indicated a potential HIF binding site for the -2578 C-allele representing an important potential inducer of VEGF expression. Additionally, linkage disequilibrium of the -2578 A-allele and an 18 bp insertion increases the number of potential TFB sites. For the VEGF promoter SNP -1154 A/G an interaction with the HRE under participation of the SNP +405 C/G was supposed. The comprehension of the association of specific SNPs and TFB could be an essential part in our understanding of individual differences of VEGF regulation and course of diseases.
Copyright © 2015. Published by Elsevier Ltd.

Entities:  

Keywords:  Review; SNP; Transcriptional regulation; VEGF; Vascular endothelial growth factor

Mesh:

Substances:

Year:  2015        PMID: 26209503     DOI: 10.1016/j.cyto.2015.07.015

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  10 in total

1.  Carfilzomib and lenalidomide response related to VEGF and VEGFR2 germline polymorphisms.

Authors:  Tristan M Sissung; Cody J Peer; Neha Korde; Sham Mailankody; Dickran Kazandjian; David J Venzon; Ola Landgren; William D Figg
Journal:  Cancer Chemother Pharmacol       Date:  2017-05-09       Impact factor: 3.333

2.  Study of the Association between VEGF Polymorphisms and the Risk of Coronary Artery Disease in Koreans.

Authors:  Eun-Ju Ko; In-Jai Kim; Jeong-Yong Lee; Hyeon-Woo Park; Han-Sung Park; Sang-Hoon Kim; Jae-Youn Moon; Jung-Hoon Sung; Nam-Keun Kim
Journal:  J Pers Med       Date:  2022-05-07

3.  Major methylation alterations on the CpG markers of inflammatory immune associated genes after IVIG treatment in Kawasaki disease.

Authors:  Sung-Chou Li; Wen-Ching Chan; Ying-Hsien Huang; Mindy Ming-Huey Guo; Hong-Ren Yu; Fu-Chen Huang; Hsing-Chun Kuo; Ho-Chang Kuo
Journal:  BMC Med Genomics       Date:  2016-08-12       Impact factor: 3.063

4.  Altered Transcription Factor Expression Responses to Exercise in Insulin Resistance.

Authors:  Rocio Zapata-Bustos; Jean Finlayson; Paul R Langlais; Dawn K Coletta; Moulun Luo; Danielle Grandjean; Elena A De Filippis; Lawrence Mandarino
Journal:  Front Physiol       Date:  2021-04-07       Impact factor: 4.566

5.  Tocilizumab (TCZ) Decreases Angiogenesis in Rheumatoid Arthritis Through Its Regulatory Effect on miR-146a-5p and EMMPRIN/CD147.

Authors:  Devy Zisman; Mirna Safieh; Elina Simanovich; Joy Feld; Amalia Kinarty; Liron Zisman; Tal Gazitt; Amir Haddad; Muna Elias; Itzhak Rosner; Lisa Kaly; Michal A Rahat
Journal:  Front Immunol       Date:  2021-12-15       Impact factor: 7.561

6.  VEGFA rs3025020 Polymorphism Contributes to CALR -Mutation Susceptibility and Is Associated with Low Risk of Deep Vein Thrombosis in Primary Myelofibrosis.

Authors:  Laura Villani; Vittorio Rosti; Margherita Massa; Rita Campanelli; Paolo Catarsi; Adriana Carolei; Carlotta Abbà; Annalisa de Silvstri; Robert Peter Gale; Giovanni Barosi
Journal:  TH Open       Date:  2021-11-09

7.  Influence of polymorphisms in the vascular endothelial growth factor gene on allograft rejection after kidney transplantation: a meta-analysis.

Authors:  Thanee Eiamsitrakoon; Phuntila Tharabenjasin; Noel Pabalan; Hamdi Jarjanazi; Adis Tasanarong
Journal:  F1000Res       Date:  2021-02-10

Review 8.  Relationship between Oxidative Stress, Circadian Rhythms, and AMD.

Authors:  María Luisa Fanjul-Moles; Germán Octavio López-Riquelme
Journal:  Oxid Med Cell Longev       Date:  2015-12-28       Impact factor: 6.543

Review 9.  The role of hypoxia-inducible factors in neovascular age-related macular degeneration: a gene therapy perspective.

Authors:  Parviz Mammadzada; Pablo M Corredoira; Helder André
Journal:  Cell Mol Life Sci       Date:  2019-12-31       Impact factor: 9.261

Review 10.  Neovascular Age-Related Macular Degeneration: Therapeutic Management and New-Upcoming Approaches.

Authors:  Federico Ricci; Francesco Bandello; Pierluigi Navarra; Giovanni Staurenghi; Michael Stumpp; Marco Zarbin
Journal:  Int J Mol Sci       Date:  2020-11-03       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.